tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Technical Analysis

Compare
244 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
NewAmsterdam Pharma Company’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting NewAmsterdam Pharma Company is a Sell.
NewAmsterdam Pharma Company’s (NAMS) 20-Day exponential moving average is 33.66, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.63, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) 50-Day exponential moving average is 33.99, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.63, making it a Buy.

NewAmsterdam Pharma Company (NAMS) Pivot Points

Feb 16, 2026, 04:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
32.59
33.35
34.10
34.86
35.62
36.37
37.13
Fibonacci
33.35
33.93
34.28
34.86
35.44
35.80
36.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NewAmsterdam Pharma Company (NAMS) Moving Averages

Feb 16, 2026, 04:30 PM
Period
Simple
Exponential
MA5
34.72Sell
34.46Buy
MA10
33.75Buy
33.98Buy
MA20
33.15Buy
33.66Buy
MA50
34.13Buy
33.99Buy
MA100
34.93Sell
33.02Buy
MA200
28.30Buy
28.37Buy
NewAmsterdam Pharma Company’s (NAMS) 10-Day exponential moving average is 33.98, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.63, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) 100-Day exponential moving average is 33.02, while NewAmsterdam Pharma Company’s (NAMS) share price is $34.63, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) stock price is $34.63 and NewAmsterdam Pharma Company’s (NAMS) 50-day simple moving average is 34.13, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $34.63 and NewAmsterdam Pharma Company’s (NAMS) 100-day simple moving average is 34.93, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $34.63 and NewAmsterdam Pharma Company’s (NAMS) 200-day simple moving average is 28.30, creating a Buy signal.

NewAmsterdam Pharma Company (NAMS) Technical Indicators

Feb 16, 2026, 04:30 PM
Name
Value
Implied Action
RSI (14)
54.84
Neutral
STOCH (9,6)
77.22
Neutral
STOCHRSI (14)
78.68
Neutral
MACD (12,26)
0.15
Sell
ADX (14)
14.64
Buy
Williams %R
-22.37
Buy
CCI (14)
107.83
Sell
ATR (14)
1.60
-
Ultimate Oscillator
55.14
Neutral
ROC
6.98
Buy
NewAmsterdam Pharma Company’s (NAMS) Relative Strength Index (RSI) is 54.84, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Trend Strength Indicator (ADX) is 14.64, creating a Buy signal.
NewAmsterdam Pharma Company’s (NAMS) Commodity Channel Index (CCI) is 107.83, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) Price Rate of Change (ROC) is 6.98, creating a Buy signal.

FAQ

Is NAMS a Buy, Hold, or Sell?
Based on NAMS’s technical indicators, NAMS is a Buy.
    What is NAMS’s RSI (14)?
    NAMS’s RSI (14) is 54.84, which suggests NAMS is a Neutral.
      What is NAMS’s MACD?
      NAMS’s MACD is 0.15, which suggests NAMS is a Sell.
        What is NAMS’s 5-day moving average?
        NAMS’s 5-day moving average is 34.72, which suggests NAMS is a Sell.
          What is NAMS’s 20-day moving average?
          NAMS 20-day moving average is 33.15, which suggests NAMS is a Buy.
            What is NAMS’s 50-day moving average?
            NAMS’s 50-day moving average is 34.13, which suggests NAMS is a Buy.
              What is NAMS’s 200-day moving average?
              NAMS’s 200-day moving average is 28.30, which suggests NAMS is a Buy.
                What is NAMS’s Williams % R (14)?
                NAMS’s Williams % R (14) is -22.37, which suggests NAMS is a Buy.
                  What is NAMS’s CCI (14)?
                  NAMS’s CCI (14) is 107.83, which suggests NAMS is a Sell.